FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

However, that ruling had conflicted with a same-day injunction out of Texas, where Donald Trump-appointed U.S. District Judge Matthew Kacsmaryk ruled the FDA should not have approved the abortion drug ...

A federal appeals court has ruled that West Virginia can limit access to mifepristone, a medication used to end early ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

A recent appellate decision that allowed West Virginia to block access to the abortion-inducing drug mifepristone is fueling ...

Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...

Castle Biosciences' DecisionDx-Melanoma test and Revolution Medicines' elironrasib cancer drug receive FDA Breakthrough Designations. Read more here.

A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...

Pro-life advocates are rejoicing after a federal appeals court ruled this week that West Virginia is within its rights to ban ...